BPA for oxervate
Ended Awarded Last action
- Contract number
- 36E79720A0004
- Awardee
-
Dompe U.s. Inc. UEI ECCDSKQAN2J3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 1 $70,914 obligated
Award facts
- Opportunity
-
- 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refresh - October 2010 - Version R4 Solicitation · VA797P12Q0002 · Posted Feb 21, 2014
- Combined order value
- $70,914 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 3% used
- $2,400,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer. The BPA, valued at $2.4 million, is for the procurement of Oxervate Ophthalmic Solution, a medication used to treat neurotrophic keratitis.
Dompe U.S. Inc. has also received multiple firm fixed price delivery orders against its General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) contract to provide Oxervate to various VA Integrated Service Networks across the country. Additionally, Dompe holds a $5 million FSS schedule contract for broader pharmaceutical supplies, as well as a previous $10 million BPA with the VA. These contract vehicles have enabled Dompe to continue supplying Oxervate and other critical medications to meet the healthcare needs of veterans.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Oxervate opothalmic solution medication | Veterans Integrated Service Network 1 (VHA) | $70,914 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79720A0004?
36E79720A0004 was awarded to Dompe U.s. Inc. by National Acquisition Center (Headquarters) on January 13, 2020.
How much is contract 36E79720A0004 worth?
Orders under 36E79720A0004 have obligated $70,914. 36E79720A0004's own ceiling is $2,400,000.
How many orders have been placed under contract 36E79720A0004?
1 order has been placed under 36E79720A0004, the latest on October 5, 2021.
Who can order from contract 36E79720A0004?
36E79720A0004 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79720A0004 under another contract?
Yes. 36E79720A0004 is a blanket purchase agreement under 36F79720D0017, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79720A0004 competed?
The extent of competition for 36E79720A0004 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV